Pacific Edge's long US wait is over – or is it?

Pacific Edge's long US wait is over – or is it?
Gavin Evans
Pacific Edge’s new contract with California-based health-provider Kaiser Permanente takes effect in November. It has been a long time coming. Trials with Kaiser – one of the biggest not-for-profit health schemes in the US – started in 2015. The contract is one of two big wins for Dunedin-based Pacific Edge this year; in July two of the firm’s bladder cancer tests were approved for funding by the US-based CMS – operators of the federal government’s Medicare and Medicaid health insurance systems – at US$760 per test. “We started to see t...

More Listed Companies

Numbers and letters for investors
Markets

Simon Robertson: Numbers and letters for investors

A plea for standardised financial reporting from NZX-listed companies.

Simon Robertson 02 Mar 2024
Market watchdog puts Fletcher result under microscope
Markets

Market watchdog puts Fletcher result under microscope

Listed firms sitting on material information a theme of NZ RegCo oversight report.

How Gentrack made its India expansion work
Markets

How Gentrack made its India expansion work

Gentrack has more than 100 staff in Pune, India.

NZME boss calls for digital platform law
Listed Companies

NZME boss calls for digital platform law

NZME CEO Michael Boggs calls for government solution to big tech bargaining imbalance.

Daniel Dunkley 21 Feb 2024